KINASE MODULATORS AND METHODS OF USE

The present invention relates to compounds of the Formula (I) and (II) wherein R, R21, R25-R33, m, n, X21-X23, and Q1 are defined herein. The compounds modulate protein kinase enzymatic activity to modulate cellular activities such as proliferation, differentiation, programmed cell death, migration...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KLEIN, RHETT, RONALD, BOWLES, OWEN, JOSEPH, BUSSENIUS, JOERG, FRANZINI, MAURIZIO, BLAZEY, CHARLES, M, CANNE BANNEN, LYNNE, JAMMALAMADAKA, VASU, DUBENKO, LARISA, COSTANZO, SIMONA, MAC, MORRISON, B, HUANG, PING, PARKS, JASON, JEVIOUS, CHAN, DIVA SZE-MING, KIM, MOON, HWAN, LE, DONNA, TRA, CO, ERICK WANG, ANAND, NEEL, K, DEFINA, STEVEN, CHARLES, CHEN, BAILI, KHOURY, RICHARD GEORGE
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to compounds of the Formula (I) and (II) wherein R, R21, R25-R33, m, n, X21-X23, and Q1 are defined herein. The compounds modulate protein kinase enzymatic activity to modulate cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly p70S6 and/or Akt kinases. Methods of using and preparing the compounds, and pharmaceutical compositions thereof, to treat kinase-dependent diseases and conditions are also an aspect of the invention.